A Mixed Meal Tolerance Test Study to Evaluate the Pharmacokinetics and Pharmacodynamics of LY900014 Compared to Humalog Following a Single Dose in Adults With Type 1 Diabetes
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Insulin lispro (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly
- 13 Sep 2018 Status changed from recruiting to completed.
- 13 Jul 2018 Planned End Date changed from 1 Jul 2018 to 1 Aug 2018.
- 13 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Aug 2018.